A soon-to-be-presented study suggests Cepham’s Furosap fenugreek ingredient may enhance testosterone levels and sperm profiles in men.
Ingredients supplier Cepham (Piscataway, NJ) says a soon-to-be-presented study suggests its Furosap fenugreek ingredient may enhance testosterone levels and sperm profiles in men.
The 12-week, one-arm, open-label study followed 50 male volunteers aged 35-65 who each received 500 mg/day of Furosap, a 20% protodioscin-enriched extract derived from fenugreek (Trigonella foenum-graecum) seeds. Study parameters included testosterone levels, sperm profile, sperm morphology, libido, erectile dysfunction, mood, and mental alertness.
According to Cepham, researchers found that 85.4% of study participants showed improvements in sperm count, and 90% of participants showed improvements in free testosterone levels. Additionally, a majority of the subjects in the study “demonstrated improvements in mental alertness and mood,” and 14.6% of volunteers experienced an improvement in sperm morphology, says Cepham.
“Overall, the results demonstrate that Furosap, enriched in 20% protodioscin, is safe and effective in attenuating testosterone levels, sperm profile, mental alertness, and overall performance in human subjects,” wrote the researchers, in an abstract provided by Cepham.
A safety parameter evaluation in the study, including extensive blood chemistry data, found no significant changes in cholesterol, hemogram (CBC), serum lipid function, triglyceride, hepatotoxicity, or nephrotoxicity as a result of the Furosap supplementation, according to Cepham.
The study results will be presented at the upcoming Experimental Biology meeting in San Diego.